Affinity Asset Advisors, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $596 Million distributed in 91 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $57.7M, Insmed Inc with a value of $47.8M, Xenon Pharmaceuticals Inc. with a value of $34.4M, Arcellx, Inc. with a value of $32.6M, and Blueprint Medicines Corp with a value of $32M.
Examining the 13F form we can see an decrease of $300M in the current position value, from $896M to 596M.
Affinity Asset Advisors, LLC is based out at New York, NY
Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.
